Gala vs WePeptideRx
Neither Gala nor WePeptideRx has an FDA warning letter on record. On brand-name semaglutide pen, WePeptideRx costs $10,800 less a year at standing rates: $399 a month against $1,299 a month at Gala. It is one of three products the two sell at comparable terms.
The record
Gala / WePeptideRx
Featured pick (affiliate partner)
Gala
8.4/10
WePeptideRx
7.6/10
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. WePeptideRx pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.4, WePeptideRx 7.6). How we are paid
What the record shows
- 01
Neither Gala nor WePeptideRx has an FDA warning letter on record.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On brand-name semaglutide pen, WePeptideRx costs $10,800 less a year at standing rates: $399 a month against $1,299 a month at Gala. It is one of three products the two sell at comparable terms.
- 04
Only WePeptideRx lists a price for brand-name tirzepatide pen.
- 05
Gala covers two states WePeptideRx does not.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Gala
WePeptideRx
$179/moLower
$2,148 a year
$189/mo
$2,268 a year
$179/moLower
$2,148 a year
$199/mo
$2,388 a year
$1,299/mo
$15,588 a year
$399/moLower
$4,788 a year
$699/mo
$8,388 a year
Read off each seller’s own pages. Gala: October 17, 2026. WePeptideRx: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Gala
8.4/10- $120 a year less on compounded semaglutide injection
- $240 a year less on compounded tirzepatide injection
- Names no compounding pharmacy
The case for WePeptideRx
7.6/10- $10,800 a year less on brand-name semaglutide pen
- Sells brand-name tirzepatide pen, which Gala does not price
- Names no compounding pharmacy
Scores
Gala 8.4 · WePeptideRx 7.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Gala vs WePeptideRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- RxSpan MD7.9
From $249/mo
Visit site - SkinnyRx5.5
From $1,400/mo
Visit site - Eden8.7
From $99/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks